CAS: 1005402-19-6
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Irdabisant REF: TM-T32191CAS: 1005402-19-6 | 99.77% | 57,00 €~1.291,00 € | Mar 21 Gen 25 |
 | Irdabisant REF: 3D-BI184163CAS: 1005402-19-6 | Min. 95% | 232,00 €~1.739,00 € | Mar 28 Gen 25 |
Irdabisant
CAS:1005402-19-6
Irdabisant (CEP-26401) is an H3R antagonist/inverse agonist, BBB permeable, with cognition-enhancing effects for schizophrenia/cognitive research.
Formula:
C18H23N3O2
Purezza:
99.77%
Colore e forma:
Solid
Peso molecolare:
313.39
Ref: TM-T32191
| 1mg | 57,00 € | ||
| 5mg | 131,00 € | ||
| 10mg | 184,00 € | ||
| 25mg | 328,00 € | ||
| 50mg | 460,00 € | ||
| 100mg | 647,00 € | ||
| 500mg | 1.291,00 € | ||
| 1mL*10mM (DMSO) | 92,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
Irdabisant
CAS:1005402-19-6
Please enquire for more information about Irdabisant including the price, delivery time and more detailed …
Formula:
C18H23N3O2
Purezza:
Min. 95%
Peso molecolare:
313.39 g/mol
Ref: 3D-BI184163
| 10mg | 232,00 € | ||
| 25mg | 436,00 € | ||
| 50mg | 647,00 € | ||
| 100mg | 986,00 € | ||
| 250mg | 1.739,00 € |
Consegna stimata in Stati Uniti, il Martedì 28 Gennaio 2025
